UBT251
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
The United Bio-Technology (Hengqin) Co · Phase 2 · Recruiting · Enrollment 333
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Part A - UBT251 | n/r | n/r | n/r | n/r | n/r |
| Part A - placebo | n/r | n/r | n/r | n/r | n/r |
| Part B - Arm A (UBT251) | n/r | n/r | n/r | n/r | n/r |
| Part B - Arm B (UBT251) | n/r | n/r | n/r | n/r | n/r |
| Part B - Arm C (UBT251) | n/r | n/r | n/r | n/r | n/r |
| Part B - Arm D (UBT251) | n/r | n/r | n/r | n/r | n/r |
| Part B - Arm E (UBT251) | n/r | n/r | n/r | n/r | n/r |
| Part B - placebo | n/r | n/r | n/r | n/r | n/r |
| Part C - UBT251 dose 1 | n/r | n/r | n/r | n/r | n/r |
| Part C - UBT251 dose 2 | n/r | n/r | n/r | n/r | n/r |
| Part C - UBT251 dose 3 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.